|
2025
|
P/S
|
EDP software for the prediction of chemical processes, preferably based on analytical data based ... |
|
|
P/S
|
Pharmaceutical preparations, namely, antithrombotic agent |
|
|
Invention
|
Fx activation process and its use in the preparation of a fxa composition.
The invention relates... |
|
|
Invention
|
Cystine knot domain fusion protein dimers. The application relates to a protein dimer formed by a... |
|
2024
|
Invention
|
C1-esterase inhibitor preparation.
The present invention relates to a stable C1-esterase-inhibit... |
|
|
P/S
|
Pharmaceuticals, especially blood products, including the following products: blood plasma prepar... |
|
|
P/S
|
Pharmaceuticals, namely, Blood plasma preparations |
|
|
P/S
|
Marketing services; product and service marketing, namely, marketing the goods and services of ot... |
|
|
Invention
|
Fviii-vwf fusion proteins with improved pharmacokinetics. The invention relates to a fusion prote... |
|
|
Invention
|
Method for the preparation of albumin solutions and uses related thereto and thereof. The present... |
|
2023
|
P/S
|
Pharmaceuticals, proteins, derived from solutions containing blood or blood plasma, including med... |
|
|
P/S
|
Pharmaceuticals, Especially Blood products, including the following products: Blood plasma prepar... |
|
|
Invention
|
Biodegradable, non-porous medical device and methods for making and using the same.
The present ... |
|
|
Invention
|
Means and methods for modifying multiple alleles.
The present invention relates to a method of m... |
|
|
Invention
|
Mold for applying a liquid onto a plasma-based or cryoprecipitate-based film and method for coati... |
|
|
Invention
|
Biodegradable, non-porous medical device and methods for making and using the same. The present i... |
|
2022
|
P/S
|
Pharmaceutical products, namely blood plasma derived products in the nature of blood plasma and b... |
|
|
P/S
|
Pharmaceutical products, namely blood plasma derived products, especially prothrombin. |
|
|
P/S
|
Pharmaceutical products, namely Protease Inhibitors, especially C1-Esterase-Inhibitors. |
|
|
P/S
|
Blood for medical purposes, blood components, namely, blood plasma, platelet-rich blood plasma, s... |
|
2021
|
Invention
|
High concentration immunoglobulin composition for pharmaceutical application. The present inventi... |
|
|
P/S
|
Advertising and business services, namely, business consulting, business administration, business... |
|
|
Invention
|
Storage stable films comprising fibrin and/or fibrinogen. Described herein are dried films compri... |
|
|
P/S
|
Advertising and business services. |
|
|
Invention
|
Polypeptides modulating siglec dependent immune responses. The invention relates to a glycosylate... |
|
2020
|
Invention
|
Plasma-based films and methods for making and using the same. The present invention relates to pl... |
|
|
Invention
|
Stabilizing buffer for factor viii and vwf.
The invention relates to a pharmaceutical compositio... |
|
|
Invention
|
Stabilizing buffer for factor viii and vwf. in vitro in vitro. |
|
2019
|
Invention
|
Fx activation process and its use in the preparation of a fxa composition. The invention relates ... |
|
2018
|
Invention
|
Protecting compositions for recombinantly produced factor viii.
A histidine-free composition com... |
|
|
Invention
|
Stabilizing agent for pharmaceutical proteins.
A method for stabilising a human blood protein or... |
|
|
Invention
|
Process for production of fibrinogen and fibrinogen produced thereby. A process for purifying fib... |
|
|
Invention
|
C1-esterase inhibitor preparation. The present invention relates to a stable C1-esterase-inhibito... |
|
|
Invention
|
Method for the production of a recombinant target protein. The present invention relates to a met... |
|
|
P/S
|
Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII.... |
|
|
P/S
|
Computer-software, especially on the basis of a mathematical model to predict pharmaco kinetics a... |
|
2017
|
Invention
|
Method for inactivation/removal of coagulation factors by precipitation. A method for inactivatio... |
|
|
P/S
|
Pharmaceutical products, namely, blood plasma derived products, especially prothrombin for the tr... |
|
|
P/S
|
Pharmaceutical products, namely, blood plasma derived products, especially prothrombin. |
|
|
P/S
|
Pharmaceutical preparations, particularly blood plasma
preparations, plasma derivatives, coagula... |
|
|
P/S
|
Treatment of materials, namely, treatment of blood or blood plasma in pharmaceutical preparations... |
|
|
Invention
|
Means and methods for modifying multiple alleles. The present invention relates to a method of mo... |
|
|
P/S
|
Pharmaceutical preparations, namely, blood clotting factors, in particular fibrinogen |
|
|
P/S
|
Pharmaceutical products, in particular medicines containing
immunoglobulin. |
|
|
Invention
|
Glycosylated vwf fusion proteins with improved pharmacokinetics. The invention relates to a fusio... |
|
|
P/S
|
Pharmaceutical preparations, particularly blood plasma preparations, plasma derivatives, coagulat... |
|
|
Invention
|
Method of separating factor viii from blood products. The invention provides a method for separat... |
|
2016
|
Invention
|
Serum-free stable transfection and production of recombinant human proteins in human cell lines. ... |
|
|
P/S
|
Pharmaceutical preparations, namely blood clotting factors,
in particular fibrinogen. |
|
|
P/S
|
Pharmaceutical products, in particular medicines containing immunoglobulin |
|
|
P/S
|
Pharmaceutical products, in particular medicines containing immunoglobulin. |
|
|
P/S
|
Pharmaceutical products, in particular medicines containing immunoglobulins extracted from blood ... |
|
|
P/S
|
Pharmaceutical products, namely blood-clotting factor, in
particular fibrinogen. |
|
|
P/S
|
Pharmaceutical preparations, namely blood clotting factors, in particular fibrinogen. |
|
|
Invention
|
Process for the purification of a growth factor protein. A method of purifying a Growth Factor Pr... |
|
|
Invention
|
Method for improved isolation of recombinantly produced proteins. The present invention provides ... |
|
|
Invention
|
Process for production of fibrinogen. The present invention relates to a method or process for th... |
|
|
Invention
|
Stabilizing agent for pharmaceutical proteins. A method for stabilizing a human blood protein or ... |
|
2015
|
Invention
|
Process for isolation and purification of a target protein free of prion protein (prpsc).
A proc... |
|
|
Invention
|
Preparation comprising factor viii and von willebrand factor peptides. A composition comprising a... |
|
|
Invention
|
Process for manufacturing factor viii having an improved ratio of fviii:c/fviii/ag. A process for... |
|
|
Invention
|
A process for manufacturing factor viii having an improved ratio of fviii:c/fviii:ag. A process f... |
|
2013
|
Invention
|
Test for hemolytic potential of pharmaceutical products and formulations for risk minimization.
... |
